After inking a string of pipeline deals, Boehringer Ingelheim is doing makeover
26 Aug 2019 //
ENDPTS
Boehringer enriches cancer immunology portfolio by AMAL Therapeutics acquisition
18 Jul 2019 //
PHARMATIMES
Boehringer buys up cancer vaccine player, eyes oncology combo strategy
16 Jul 2019 //
FIERCE BIOTECH